WINDLAS.NS

Healthcare Drug Manufacturers - Specialty & Generic

Windlas Biotech Limited

₹949.20
-42.40 -4.28% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 9, 2026, live at 3:55 PM ET949.20

Key Stats

Market Cap
19.59B
Avg Volume
150,647
P/E (TTM)
30.36
EPS
₹31.26
52W High
₹1,181.90
52W Low
₹697.40
Div. Yield
0.0%

Valuation

P/B Ratio
3.45
P/S Ratio
2.08
EV/EBITDA
18.34
EV/Revenue
1.98

Margins

Gross Margin 38.0%
Operating Margin 7.8%
Net Margin 7.1%
EBITDA Margin 10.8%

Growth & Returns

Revenue Growth (YoY)
18.1%
Earnings Growth (YoY)
(0.2%)
Earnings Growth (QoQ)
(0.1%)

Liquidity & Leverage

Debt / Equity
0.06
Total Cash
2.79B
Total Debt
352.42M

About

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. The company sells generic medicines, health supplements, and custom-branded formulations under Windlas brand names. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

windlas.com